AYAlexey Viktorovich Yantsevich

Alexey Viktorovich Yantsevich

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexey Viktorovich Yantsevich has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gene Therapy Using a VEGF165/Ang-1 Plasmid Construct: Evaluation of Vascular Density in Chronic Hindlimb Ischemia in Rats

    by V. G. Bogdan, T. A. Filipovich, E. V. Fiodorova, I. P. Zhavoronok, A. S. Doronkina, А. V. Yantsevich, S. V. Mankovskaya, В. Г. Богдан, Т. А. Филипович, Е. В. Федорова, et al.

    Introduction . The prevalence of chronic lower limb ischemia among individuals over 50 years of age does not exceed 8 % . However, in the presence of risk factors such as smoking, diabetes mellitus, or hypertension, the risk of its development increases to 30 % . This study evaluates the efficacy of therapeutic angiogenesis using a combined circular DNA-based construct. Objective . To determine, in an in vivo experiment, the features of the dynamics of blood vessel density changes in the ischemic muscles of the rat hind limb after local application of a plasmid construct containing gene segments encoding vascular endothelial growth factor 165 and angiopoietin-1 (pcDNA_VEGF165/Ang-1). Materials and Methods . Three observation groups were formed: «CHI» (chronic hindlimb ischemia without treatment; n=12), «CHI + PSS» (administration of pyrogen-free physiological saline, 200 μL; n=12), and the experimental «CHI + VEGF165/Ang-1» group (administration of pcDNA_VEGF165/Ang-1 at a dose of 100 μg/animal; n=24). The solutions were administered once intramuscularly into the animal’s right hindlimb. An immunohistochemical examination of the skeletal muscle tissue of the thigh and lower leg was performed using monoclonal antibodies against blood vessel endothelial cells (CD31) and against smooth muscle α-actin (α-SMA). Results . The use of the combined VEGF165/Ang-1 plasmid led to a statistically significant stimulation of angiogenesis and arteriogenesis, which made it possible to completely restore vascular density in the ischemic limb to the level of a healthy limb. In contrast to the persistent ischemic decrease in the number of microvessels in the control groups («CHI» and «CHI + PSS»), gene therapy ensured a steady increase in the vascular network. By day 28, the density of CD31-positive capillaries in the thigh and lower leg increased by 55.3 % and 33.3 %, respectively, and the density of α-SMA-positive arterioles increased by 42.2 % and 44.5 %, respectively, reaching normal values. Conclusion . The use of a domestic plasmid construct containing the genes of the angiogenesis-activating proteins VEGF165 and Ang-1 (pcDNA_VEGF165/Ang-1) in chronic hindlimb ischemia in rats accelerates capillarogenesis and arteriogenesis in ischemic lower leg muscles starting from day 14, and in the thigh muscles from day 28 after administration, as evidenced by a significant increase in the density values of CD31-positive capillaries and α-SMA-positive arterioles.

  • Design and Characterization of the Fusion Enzyme of Bovine Terminal Deoxynucleotidyl Transferase and DNA Binding Protein Sso7d from Sulfolobus solfataricus

    by Antos B. Sachanka, Yaraslau U. Dzichenka, Veronika V. Shchur, Aliaksei V. Yantsevich

    The terminal deoxynucleotidyl transferase is a unique polymerase that incorporates nucleotides at the 3′‐terminus of single‐stranded DNA primers in a template‐independent manner. This biological function propels the development of numerous biomedical and bioengineering applications. However, the extensive use of TdT is constrained by its low expression levels in E. coli and low optimal operating temperature. To address these limitations, a fusion enzyme combining TdT and the DNA‐binding protein Sso7d from Sulfolobus solfataricus is designed and isolated. This fusion protein exhibits a threefold increase in DNA‐binding affinity to double‐stranded DNA and demonstrates improved thermostability, denaturing at temperatures up to 48 °C, along with an enhancement in the expression yield of the target protein. The fusion of Sso7d to the C‐terminus of TdT enhances catalytic activity for nucleotide removal from the coding end, while completely abolishing nucleotide addition activity. Conversely, the presence of Sso7d at the N‐terminus of TdT decreases nucleotide incorporation and enhances nucleotide removal activity, with this effect significantly influenced by substrate length and the presence of metal ions in the reaction mixture. Overall, the obtained fusion enzymes could serve as promising candidates for novel specific applications, such as gene editing, mutagenesis studies, and aptamer engineering.

  • Open Access

    Biologically Active Dairy Protein Hydrolysates and Their Cyclodextrin Inclusion Complexes: Biotechnological Aspects of Production

    by Tatsiana Halavach, Zenon Lovkis, Vladimir Kurchenko, Aleksei Yantsevich, Ekaterina Tarun, Natalia Dudchik, Igor Rzhepakovsky, Aleksei Lodygin

    Enzymatic hydrolysis of dairy proteins increases their nutritional and biological value while reducing their allergenic potential. The subsequent complexation of peptides with cyclodextrins (CDs) reduces the bitterness of the hydrolyzed proteins. The research objective was to obtain hydrolysates of whey proteins and their cyclodextrin inclusion complexes with peptides, as well as to describe the peptide composition of the cleaved dairy proteins, biological activity, and sensory profile of the hydrolysates and inclusion complexes. The research featured enzymatic whey protein hydrolysates with an extensive hydrolysis degree and their inclusion complexes with β- and γ-CDs. Dairy proteins were hydrolyzed with alcalase, and the hydrolysates obtained were subjected to micro- and ultrafiltration (cut-off limit – 10 kDa). The peptide composition of the hydrolyzed proteins was determined by the methods of high-performance liquid chromatography and chromatography-mass spectrometry. The antimutagenic activity was evaluated using the Ames test whereas the antibacterial effect was studied with the impedimetric method. The antioxidant activity was detected with fluorimetry and spectrophotometry. The method of competitive enzyme immunoassay was applied to reveal the antigenic properties. The bitterness of the experimental sample s was determined by a sensory evaluation. The research delivered the optimal modes for whey protein cleavage with alcalase that made it possible to achieve efficient micro- and ultrafiltration. The resulting hypoallergenic peptide fractions and their inclusion complexes with β- and γ-CDs possessed antioxidant, antibacterial, and antimutagenic properties. The whey proteolysis and subsequent filtration with/without tindalization demonstrated a 265/589-fold decrease in the residual antigenicity. The fluorimetric method showed a 1.79/1.90-fold increase in the antioxidant activity of the hydrolysate in complexes with β- and γ-CDs. Binding of β-CDs to peptides enhanced their antimicrobial activity against Escherichia coli ATCC 8739 and Staphylococcus aureus ATCC 6538. The hydrolysate samples with β-CDs showed less bitterness. Whey proteolysis with alcalase under optimized conditions and subsequent fractionation resulted in a product with high consumer qualities. Enzymatic hydrolysates of dairy proteins and their CD inclusion complexes were able to substitute native protein components. Their bioactive properties, good taste, and low allergenic potential mean good prospects for the functional food industry.


  • Hydrolyzed Collagen Quality Control by Dynamic Light Scattering

    by A. E. Dmitrochenko, V. V. Shchur, T. E. Kasko, S. A. Usanov, A. V. Yantsevich

  • Open Access

    Expression and purification of recombinant thermostable DNA-binding protein Sso7d

    by A. B. Sachanka, M. Trawkina, V. V. Shchur, S. A. Usanov, A. V. Yantsevich

    Белок Sso7d обладает исключительной стабильностью структуры, а также способностью высокоспецифично связываться с ДНК, что делает белок перспективным модулем для создания химерных белков и тест-систем. Sso7d является компонентом химерных высокоточных ДНК-полимераз, способных осуществлять полимеразную цепную реакцию даже в присутствии ингибиторов ПЦР. Применение более быстрого, простого и высокопроизводительного метода получения белка позволит существенно сократить расходы на создание биосенсоров и на проведение анализов. Описан новый эффективный способ получения рекомбинантного белка Sso7d с высокой степенью чистоты без использования аффинной хроматографии.

  • CURCUMINOIDS: RECOVERY, PROPERTIES AND APPLICATION REPORT 1. RECOVERY OF CURCUMINOIDS AND THEIR PHYSICAL AND CHEMICAL PROPERTIES

    by Maxim Alexandrovich Kapustin, Anna Sergeyevna Chubarova, Ivan Alekseevich Evdokimov, Alexey Dmitrievich Lodigin, Svetlana Valentinovna Lodigina, Alexey Viktorovich Yantsevich, Vladimir Petrovich Kurchenko

    Разработана ВЭЖХ методика качественного и количественного определения куркуминоидов (куркумина, деметоксикуркумина, бис-деметоксиксикуркумина). Описана процедура извлечения суммарного препарата куркуминоидов из растительного материала (Curcuma longa L.) с использованием различных экстрагентов. Приведены условия препаративного выделения индивидуальных куркуминоидов. Изучены физико-химические свойства полученных соединений. Разработана принципиальная технологическая схема получения куркуминоидов из растительного...

  • 5′-DMT-protected double-stranded DNA: Synthesis and competence to enzymatic reactions

    by Veronika V. Shchur, Yuliya P. Burankova, Andrei I. Zhauniarovich, Yaraslau V. Dzichenka, Sergei A. Usanov, Aleksei V. Yantsevich


  • Modified bile acids and androstanes—Novel promising inhibitors of human cytochrome P450 17A1

    by Yaraslau Dzichenka, Michail Shapira, Aliaksei Yantsevich, Tatsiana Cherkesova, Ljubica Grbović, Marina Savić, Sergey Usanov, Suzana Jovanović-Šanta


  • Open Access

    In silico analysis of interaction of compounds, containing photoactivatable groups,with human CYP7 enzymes

    by Ya. U. Dzichenka, M. S. Horetski, Ya. V. Faletrov, A. V. Yantsevich, V. M. Shkumatov, S. A. Usanov

    С целью выявления структурных особенностей взаимодействия ферментов CYP7 человека с производными бордипирометена (BODIPY) и стероидов, содержащих фотоактивируемые сшивающие группы, проведен in silico анализ комплексов «белок-лиганд». Показано, что модифицированные молекулы BODIPY, а также производное дегидроэпиандростерона с диазириновой группой способны связываться в активном центре стероид-гидроксилаз человека с аффинностью, сравнимой с соответствующими величинами, рассчитанными для природных субстратов этих ферментов. При этом геометрия комплекса «фермент-лиганд» для модифицированного стероида в активном центре также соответствует геометрии комплексов CYP7 со своими природными лигандами, что указывает на возможность образования гидроксилированных продуктов реакции - меченых аналогов биометаболитов. Показано, что наличие одновременно диазириновой и 7-нитробензофуразановой групп значительно снижает сродство лиганда к активному центру CYP7A1 и, в особенности, CYP7B1. Идентифицированы аминокислотные остатки, расположенные вблизи фотоактивируемых групп и способные образовывать с ними ковалентные аддукты. Полученные результаты представляют интерес для объяснения механизма взаимодействия соединений, содержащих фотоактивируемые сшивающие группы с рекомбинантными ферментами CYP7 человека in vitro, а также для идентификации продуктов ковалентной модификации аминокислотных остатков белка, образующихся при фотоактивации исследованных молекул.

  • Open Access

    In silico analysis of the phosphorylation effect on the structure of the human sterol-hydroxylases CYP17A1 AND CYP19A1

    by Ya. U. Dzichenka, M. Trawkina, A. V. Yantsevich, S. A. Usanov, Я. В. Диченко

    In silico анализ влияния фосфорилирования на структуру стероид-гидроксилаз человека CYP17A1 И CYP19A1